Cardiac Fibrosis: The Beneficial Effects of Exercise in Cardiac Fibrosis

Back

Bibliographic information

Publication year
2017
Category
AEC — Scientific works in foreign peer-reviewed scientific proceedings, monographs
CREPČ / EPCA ID
0039361
Document type
Article in proceedings
Source
Exercise for Cardiovascular Disease Prevention and Treatment
ISBN (Source)
978-981-10-4306-2
ISSN (Source)
0065-2598
Volume
S. 257-268 [1,09AH]
Issue
1. vyd.
Source publication year
2017
Language
English
Research areas
180 — Medical, pharmaceutical and non-medical health sciences

Bibliographic record

KYSELOVIČ, Ján - LEDDY, John J. Cardiac Fibrosis: The Beneficial Effects of Exercise in Cardiac Fibrosis. In: Exercise for Cardiovascular Disease Prevention and Treatment : XIAO, Junjie. From Molecular to Clinical, Part 1. 1. vyd. Singapore : Springer Nature, 2017. ISBN 978-981-10-4306-2 - ISSN 0065-2598, s. 257-268 [1,09AH].

Publication authors

AuthorRoleShare
Ján KyselovičAuthor50.000 %
John J. LeddyAuthor50.000 %

Citations (2)

Citation year / CategoryCitationsSource
2021
1

AMEDRO, Pascal - WERNER, Oscar - ABASSI, Hamouda - BOISSON, Aymeric - SOUILLA, Luc - GUILLAUMONT, Sophie - CALDERON, Johanna - REQUIRAND, Anne - VINCENTI, Marie - POMMIER, Victor - MATECKI, Stefan - DE LA VILLEON, Gregoire - LAVASTRE, Kathleen - LACAMPAGNE, Alain - PICOT, Marie Christine - BEYLER, Constance - DELCLAUX, Christophe - DULAC, Yves - GUITARTE, Aitor - CHARRON, Philippe - DENJOY-URBAIN, Isabelle - PROBST, Vincent - BARUTEAU, Alban Elouen - CHEVALIER, Philippe - DI FILIPPO, Sylvie - THAMBO, Jean Benoit - BONNET, Damien - PASQUIE, Jean Luc. Health-related quality of life and physical activity in children with inherited cardiac arrhythmia or inherited cardiomyopathy: the prospective multicentre controlled QUALIMYORYTHM study rationale, design and methods. In Health and Quality of Life Outcomes, 2021-12-01, 19, 1, pp. Dostupné na: https://doi.org/10.1186/s12955-021-01825-6.

Scopus
2021
1

WANG, Xiaoling - HUANG, Ting - XIE, Han. CTRP12 alleviates isoproterenol induced cardiac fibrosis via inhibiting the activation of P38 pathway. In Chemical and Pharmaceutical Bulletin. ISSN 00092363, 2021-02-01, 69, 2, pp. 178-184. Dostupné na: https://doi.org/10.1248/cpb.c19-01109.

Scopus